309 related articles for article (PubMed ID: 8842452)
21. Cyclosporin A-loaded poly(ethylene glycol)-b-poly(d,l-lactic acid) micelles: preparation, in vitro and in vivo characterization and transport mechanism across the intestinal barrier.
Zhang Y; Li X; Zhou Y; Fan Y; Wang X; Huang Y; Liu Y
Mol Pharm; 2010 Aug; 7(4):1169-82. PubMed ID: 20540526
[TBL] [Abstract][Full Text] [Related]
22. Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone.
Jin M; Shimada T; Yokogawa K; Nomura M; Kato Y; Tsuji A; Miyamoto K
Int J Pharm; 2006 Feb; 309(1-2):81-6. PubMed ID: 16384676
[TBL] [Abstract][Full Text] [Related]
23. Effect of PSC 833 liposomes and Intralipid on the transport of epirubicin in Caco-2 cells and rat intestines.
Lo Y; Liu F; Cherng J
J Control Release; 2001 Sep; 76(1-2):1-10. PubMed ID: 11532308
[TBL] [Abstract][Full Text] [Related]
24. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells.
Cavet ME; West M; Simmons NL
Br J Pharmacol; 1996 Jul; 118(6):1389-96. PubMed ID: 8832062
[TBL] [Abstract][Full Text] [Related]
25. Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake.
Gutmann H; Fricker G; Török M; Michael S; Beglinger C; Drewe J
Pharm Res; 1999 Mar; 16(3):402-7. PubMed ID: 10213371
[TBL] [Abstract][Full Text] [Related]
26. pH dependent uptake of loperamide across the gastrointestinal tract: an in vitro study.
Crowe A; Wong P
Drug Dev Ind Pharm; 2004 May; 30(5):449-59. PubMed ID: 15244080
[TBL] [Abstract][Full Text] [Related]
27. Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells.
Chiodini B; Bassan R; Barbui T
Leuk Lymphoma; 1999 May; 33(5-6):485-97. PubMed ID: 10342576
[TBL] [Abstract][Full Text] [Related]
28. Active transepithelial transport of irinotecan (CPT-11) and its metabolites by human intestinal Caco-2 cells.
Yamamoto W; Verweij J; de Bruijn P; de Jonge MJ; Takano H; Nishiyama M; Kurihara M; Sparreboom A
Anticancer Drugs; 2001 Jun; 12(5):419-32. PubMed ID: 11395570
[TBL] [Abstract][Full Text] [Related]
29. Absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats.
Wang XQ; Dai JD; Zhang H; Zhang X; Wang JC; Zhang Q
J Nanosci Nanotechnol; 2008 May; 8(5):2422-31. PubMed ID: 18572658
[TBL] [Abstract][Full Text] [Related]
30. Nonlinear intestinal absorption of 5-hydroxytryptamine receptor antagonist caused by absorptive and secretory transporters.
Tamai I; Saheki A; Saitoh R; Sai Y; Yamada I; Tsuji A
J Pharmacol Exp Ther; 1997 Oct; 283(1):108-15. PubMed ID: 9336314
[TBL] [Abstract][Full Text] [Related]
31. Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells.
Chiu YY; Higaki K; Neudeck BL; Barnett JL; Welage LS; Amidon GL
Pharm Res; 2003 May; 20(5):749-56. PubMed ID: 12751630
[TBL] [Abstract][Full Text] [Related]
32. The role of P-glycoprotein in determining the oral absorption and clearance of the NK2 antagonist, UK-224,671.
Beaumont K; Harper A; Smith DA; Bennett J
Eur J Pharm Sci; 2000 Nov; 12(1):41-50. PubMed ID: 11121732
[TBL] [Abstract][Full Text] [Related]
33. Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs.
Sha X; Fang X
Int J Pharm; 2004 Mar; 272(1-2):161-71. PubMed ID: 15019079
[TBL] [Abstract][Full Text] [Related]
34. Limited influence of P-glycoprotein on small-intestinal absorption of cilostazol, a high absorptive permeability drug.
Toyobuku H; Tamai I; Ueno K; Tsuji A
J Pharm Sci; 2003 Nov; 92(11):2249-59. PubMed ID: 14603510
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.
Liang E; Proudfoot J; Yazdanian M
Pharm Res; 2000 Oct; 17(10):1168-74. PubMed ID: 11145220
[TBL] [Abstract][Full Text] [Related]
36. Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion.
Boyd RA; Stern RH; Stewart BH; Wu X; Reyner EL; Zegarac EA; Randinitis EJ; Whitfield L
J Clin Pharmacol; 2000 Jan; 40(1):91-8. PubMed ID: 10631627
[TBL] [Abstract][Full Text] [Related]
37. Hepatocellular effects of cyclosporine A and its derivative SDZ IMM 125 in vitro.
Wolf A; Schramm U; Fahr A; Aicher L; Cordier A; Trommer WE; Fricker G
J Pharmacol Exp Ther; 1998 Mar; 284(3):817-25. PubMed ID: 9495838
[TBL] [Abstract][Full Text] [Related]
38. Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine.
Saitoh H; Aungst BJ
Pharm Res; 1995 Sep; 12(9):1304-10. PubMed ID: 8570526
[TBL] [Abstract][Full Text] [Related]
39. Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers.
Hunter J; Hirst BH; Simmons NL
Pharm Res; 1993 May; 10(5):743-9. PubMed ID: 8100632
[TBL] [Abstract][Full Text] [Related]
40. P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers.
Maeng HJ; Yoo HJ; Kim IW; Song IS; Chung SJ; Shim CK
J Pharm Sci; 2002 Dec; 91(12):2614-21. PubMed ID: 12434406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
